Sharecare (SHCR) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SHCR Stock Forecast

Sharecare stock forecast is as follows: an average price target of $3.14 (represents a 119.58% upside from SHCR’s last price of $1.43) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

SHCR Price Target

The average price target for Sharecare (SHCR) is $3.14 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $1.43. This represents a potential 119.58% upside from SHCR's last price of $1.43.

SHCR Analyst Ratings

Buy

According to 3 Wall Street analysts, Sharecare's rating consensus is 'Buy'. The analyst rating breakdown for SHCR stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Sharecare Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jun 24, 2024	Craig Hettenbach	Morgan Stanley	-	-	4.38%	-
Nov 11, 2022		Canaccord Genuity	-	-	73.41%	109.79%
Oct 05, 2022	David Larsen	BTIG	-	-	145.10%	249.65%

Row per page

Go to

The latest Sharecare stock forecast, released on Jun 24, 2024 by Craig Hettenbach from Morgan Stanley, set a price target of $1.43, which represents a 4.38% increase from the stock price at the time of the forecast ($1.37), and a 0.00% decrease from SHCR last price ($1.43).

Sharecare Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$1.43
Last Closing Price	$1.43	$1.43	$1.43
Upside/Downside	-100.00%	-100.00%	-

In the current month, the average price target of Sharecare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sharecare's last price of $1.43. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jun 24, 2024	Morgan Stanley	Buy	Buy	Hold
Jun 24, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
Apr 01, 2024	BTIG	Buy	Neutral	Downgrade
Nov 11, 2022	Canaccord Genuity	Buy	Buy	Hold
Oct 05, 2022	BTIG	Buy	Buy	Hold

Row per page

Go to

Sharecare's last stock rating was published by Morgan Stanley on Jun 24, 2024. The company gave SHCR a "Buy" rating, the same as its previous rate.

Sharecare Financial Forecast

Sharecare Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Revenue	-	-	-	-	-	-	-	-	$105.28M	-	$110.35M	$116.30M	$123.26M	$114.62M	$103.82M	$100.71M	$118.54M	$105.62M	-
Avg Forecast	$118.60M	$115.80M	$102.10M	$98.30M	$109.70M	$106.90M	$94.50M	$101.53M	$115.00M	$113.68M	$109.77M	$110.90M	$120.25M	$109.07M	$102.91M	$96.94M	$121.05M	$103.52M	$95.70M
High Forecast	$118.60M	$115.80M	$102.10M	$98.30M	$109.70M	$106.90M	$94.50M	$101.53M	$115.00M	$113.69M	$109.77M	$110.90M	$120.25M	$109.07M	$102.91M	$96.94M	$121.05M	$103.52M	$95.70M
Low Forecast	$118.60M	$115.80M	$102.10M	$98.30M	$109.70M	$106.90M	$94.50M	$101.53M	$115.00M	$113.66M	$109.77M	$110.90M	$120.25M	$109.07M	$102.91M	$96.94M	$121.05M	$103.52M	$95.70M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	0.92%	-	1.01%	1.05%	1.03%	1.05%	1.01%	1.04%	0.98%	1.02%	-

Sharecare's average Quarter revenue forecast for Mar 24 based on 1 analysts is $101.53M, with a low forecast of $101.53M, and a high forecast of $101.53M. SHCR's average Quarter revenue forecast represents a -3.56% decrease compared to the company's last Quarter revenue of $105.28M (Dec 23).

Sharecare EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	$-16.72M	$-10.31M	$-20.95M	$-19.76M	$-10.87M	$-12.51M	$-24.19M	$-40.20M	$21.84M	$-22.04M	$-918.67K
Avg Forecast	$-5.73M	$-5.60M	$-4.93M	$-4.75M	$-5.30M	$-5.17M	$-4.57M	$-4.91M	$-5.56M	$-5.49M	$-5.30M	$-5.36M	$-5.81M	$-5.27M	$-4.97M	$-4.68M	$-5.85M	$-5.00M	$-4.62M
High Forecast	$-5.73M	$-5.60M	$-4.93M	$-4.75M	$-5.30M	$-5.17M	$-4.57M	$-4.91M	$-5.56M	$-5.49M	$-5.30M	$-5.36M	$-5.81M	$-5.27M	$-4.97M	$-4.68M	$-5.85M	$-5.00M	$-4.62M
Low Forecast	$-5.73M	$-5.60M	$-4.93M	$-4.75M	$-5.30M	$-5.17M	$-4.57M	$-4.91M	$-5.56M	$-5.49M	$-5.30M	$-5.36M	$-5.81M	$-5.27M	$-4.97M	$-4.68M	$-5.85M	$-5.00M	$-4.62M
Surprise %	-	-	-	-	-	-	-	-	3.01%	1.88%	3.95%	3.69%	1.87%	2.37%	4.86%	8.58%	-3.73%	4.41%	0.20%

1 analysts predict SHCR's average Quarter EBITDA for Mar 22 to be $-4.68M, with a high of $-4.68M and a low of $-4.68M. This is -121.45% lower than Sharecare's previous annual EBITDA (Dec 21) of $21.84M.

Sharecare Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	$-34.24M	$-24.45M	$-35.14M	$-35.01M	$-24.20M	$-27.46M	$-29.52M	$-38.30M	$6.52M	$-43.12M	$-918.67K
Avg Forecast	$-12.61M	$-16.22M	$-16.22M	$-18.02M	$-21.62M	$-23.43M	$-18.02M	$-19.82M	$-8.41M	$-8.41M	$-9.01M	$-12.61M	$-10.81M	$-9.91M	$-21.62M	$-14.42M	$-11.35M	$-11.25M	$-5.27B
High Forecast	$-12.61M	$-16.22M	$-16.22M	$-18.02M	$-21.62M	$-23.43M	$-18.02M	$-19.82M	$-8.41M	$-8.41M	$-9.01M	$-12.61M	$-10.81M	$-9.91M	$-21.62M	$-14.42M	$-11.35M	$-11.25M	$-5.27B
Low Forecast	$-12.61M	$-16.22M	$-16.22M	$-18.02M	$-21.62M	$-23.43M	$-18.02M	$-19.82M	$-8.41M	$-8.41M	$-9.01M	$-12.61M	$-10.81M	$-9.91M	$-21.62M	$-14.42M	$-11.35M	$-11.25M	$-5.27B
Surprise %	-	-	-	-	-	-	-	-	4.07%	2.91%	3.90%	2.78%	2.24%	2.77%	1.37%	2.66%	-0.57%	3.83%	0.00%

Sharecare's average Quarter net income forecast for Mar 22 is $-14.42M, with a range of $-14.42M to $-14.42M. SHCR's average Quarter net income forecast represents a -321.21% decrease compared to the company's last Quarter net income of $6.52M (Dec 21).

Sharecare SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	$46.83M	$48.80M	$50.33M	$49.47M	$48.94M	$50.58M	$57.65M	$70.51M	$66.89M	$75.13M	$878.37K
Avg Forecast	$46.70M	$45.60M	$40.20M	$38.71M	$43.19M	$42.09M	$37.21M	$39.98M	$45.28M	$44.76M	$43.22M	$43.67M	$47.35M	$42.95M	$40.52M	$38.17M	$47.67M	$40.76M	$37.68M
High Forecast	$46.70M	$45.60M	$40.20M	$38.71M	$43.19M	$42.09M	$37.21M	$39.98M	$45.28M	$44.77M	$43.22M	$43.67M	$47.35M	$42.95M	$40.52M	$38.17M	$47.67M	$40.76M	$37.68M
Low Forecast	$46.70M	$45.60M	$40.20M	$38.71M	$43.19M	$42.09M	$37.21M	$39.98M	$45.28M	$44.76M	$43.22M	$43.67M	$47.35M	$42.95M	$40.52M	$38.17M	$47.67M	$40.76M	$37.68M
Surprise %	-	-	-	-	-	-	-	-	1.03%	1.09%	1.16%	1.13%	1.03%	1.18%	1.42%	1.85%	1.40%	1.84%	0.02%

Sharecare's average Quarter SG&A projection for Mar 24 is $39.98M, based on 1 Wall Street analysts, with a range of $39.98M to $39.98M. The forecast indicates a -14.63% fall compared to SHCR last annual SG&A of $46.83M (Dec 23).

Sharecare EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	$-0.10	$-0.07	$-0.10	$-0.10	$-0.07	$-0.08	$-0.09	$-0.11	$0.02	$-0.13	$-0.06
Avg Forecast	$-0.04	$-0.04	$-0.04	$-0.05	$-0.06	$-0.07	$-0.05	$-0.06	$-0.02	$-0.02	$-0.03	$-0.04	$-0.03	$-0.03	$-0.06	$-0.04	$-0.03	$-0.03	$-14.62
High Forecast	$-0.04	$-0.04	$-0.04	$-0.05	$-0.06	$-0.07	$-0.05	$-0.06	$-0.02	$-0.02	$-0.03	$-0.04	$-0.03	$-0.03	$-0.06	$-0.04	$-0.03	$-0.03	$-14.62
Low Forecast	$-0.04	$-0.04	$-0.04	$-0.05	$-0.06	$-0.07	$-0.05	$-0.06	$-0.02	$-0.02	$-0.03	$-0.04	$-0.03	$-0.03	$-0.06	$-0.04	$-0.03	$-0.03	$-14.62
Surprise %	-	-	-	-	-	-	-	-	4.17%	2.98%	3.97%	2.83%	2.32%	2.85%	1.42%	2.75%	-0.62%	4.16%	0.00%

According to 1 Wall Street analysts, Sharecare's projected average Quarter EPS for Mar 22 is $-0.04, with a low estimate of $-0.04 and a high estimate of $-0.04. This represents a -305.13% decrease compared to SHCR previous annual EPS of $0.02 (Dec 21).

Sharecare Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
HCAT	Health Catalyst	-	-	281.85%	Buy
EVH	Evolent Health	-	-	252.55%	Buy
DH	Definitive Healthcare	-	-	123.53%	Hold
SHCR	Sharecare	-	-	119.58%	Buy
FORA	Forian	-	-	115.31%	Buy
PRVA	Privia Health Group	-	-	60.44%	Buy
HQY	HealthEquity	-	-	-7.31%	Buy
HSTM	HealthStream	-	-	-8.86%	Buy

SHCR Forecast FAQ

Is Sharecare a good buy?

Yes, according to 3 Wall Street analysts, Sharecare (SHCR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of SHCR's total ratings.

What is SHCR's price target?

Sharecare (SHCR) average price target is $3.14 with a range of $1.43 to $5, implying a 119.58% from its last price of $1.43. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Sharecare stock go up soon?

According to Wall Street analysts' prediction for SHCR stock, the company can go up by 119.58% (from the last price of $1.43 to the average price target of $3.14), up by 249.65% based on the highest stock price target, and down by 0% based on the lowest stock price target.

Can Sharecare stock reach $2?

SHCR's average twelve months analyst stock price target of $3.14 supports the claim that Sharecare can reach $2 in the near future.

What are Sharecare's analysts' financial forecasts?

Sharecare's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $412.63M (high $412.63M, low $412.63M), average EBITDA is $-19.937M (high $-19.937M, low $-19.937M), average net income is $-82.892M (high $-82.892M, low $-82.892M), average SG&A $162.47M (high $162.47M, low $162.47M), and average EPS is $-0.23 (high $-0.23, low $-0.23). SHCR's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $434.8M (high $434.8M, low $434.8M), average EBITDA is $-21.008M (high $-21.008M, low $-21.008M), average net income is $-63.07M (high $-63.07M, low $-63.07M), average SG&A $171.2M (high $171.2M, low $171.2M), and average EPS is $-0.175 (high $-0.175, low $-0.175).

Did the SHCR's actual financial results beat the analysts' financial forecasts?

Based on Sharecare's last annual report (Dec 2023), the company's revenue was $445.25M, which missed the average analysts forecast of $449.34M by -0.91%. Apple's EBITDA was $-68.842M, beating the average prediction of $-21.711M by 217.09%. The company's net income was $-128M, beating the average estimation of $-38.443M by 234.26%. Apple's SG&A was $195.43M, beating the average forecast of $176.93M by 10.46%. Lastly, the company's EPS was $-0.36, beating the average prediction of $-0.107 by 237.50%. In terms of the last quarterly report (Dec 2023), Sharecare's revenue was $105.28M, missing the average analysts' forecast of $115M by -8.45%. The company's EBITDA was $-16.719M, beating the average prediction of $-5.556M by 200.90%. Sharecare's net income was $-34.245M, beating the average estimation of $-8.409M by 307.23%. The company's SG&A was $46.83M, beating the average forecast of $45.28M by 3.42%. Lastly, the company's EPS was $-0.0974, beating the average prediction of $-0.0233 by 317.43%